pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·1h ago·1 min read
save

Klomp, Warren spar over MFN deal contracts

Top HHS official Chris Klomp had a relatively mild nomination hearing with senators on Tuesday, but he sparred with Sen. Elizabeth Warren (D-MA) over voluntary agreements with large drugmakers and what, exactly, the details of ...

Sep 15, 2026·read at Endpoints ↗

Deputy Secretary of HHS nominee Chris Klomp testifies at a Senate Finance Committee confirmation hearing on Capitol Hill on Sept. 15, 2026 (Manuel Balce Ceneta/AP Images) September 15, 2026 02:45 PM EDT Pharma HHS of­fi­cial Klomp spars with War­ren over drug pric­ing con­tracts Max Bayer Senior Reporter Top HHS of­fi­cial Chris Klomp had a rel­a­tive­ly mild nom­i­na­tion hear­ing with sen­a­tors on Tues­day, but he sparred with Sen. Eliz­a­beth War­ren (D-MA) over vol­un­tary … Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
107 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 3h agoFDA approves first radioligand generic, setting up rivalry with NovartisEndpoints
  • 3h agoCentric Compounding recalls three injectables over contaminationEndpoints
  • 4h agoSionna cuts nearly half of staff as it lines up second attempt at cystic fibrosisEndpoints
  • 4h agoRocket's Danon plans; Novo leaves Ascendis; Lilly's latest dealEndpoints
  • 5h agoGSK to wind down German vaccine factory due to lack of demandEndpoints